Elsevier

The Lancet Oncology

Volume 20, Issue 5, May 2019, Pages e253-e261
The Lancet Oncology

Series
Digital pathology and artificial intelligence

https://doi.org/10.1016/S1470-2045(19)30154-8Get rights and content

Summary

In modern clinical practice, digital pathology has a crucial role and is increasingly a technological requirement in the scientific laboratory environment. The advent of whole-slide imaging, availability of faster networks, and cheaper storage solutions has made it easier for pathologists to manage digital slide images and share them for clinical use. In parallel, unprecedented advances in machine learning have enabled the synergy of artificial intelligence and digital pathology, which offers image-based diagnosis possibilities that were once limited only to radiology and cardiology. Integration of digital slides into the pathology workflow, advanced algorithms, and computer-aided diagnostic techniques extend the frontiers of the pathologist's view beyond a microscopic slide and enable true utilisation and integration of knowledge that is beyond human limits and boundaries, and we believe there is clear potential for artificial intelligence breakthroughs in the pathology setting. In this Review, we discuss advancements in digital slide-based image diagnosis for cancer along with some challenges and opportunities for artificial intelligence in digital pathology.

Introduction

Digital pathology has a crucial role in modern clinical practice and is increasingly a technology requirement within the laboratory environment.1, 2 Advances in computing power, faster networks, and cheaper storage have enabled pathologists to manage digital slide images with more ease and flexibility than they could in the past and has enabled pathologists to share images for telepathology and clinical use. In the last two decades, digital imaging in pathology has seen the inception and evolution of whole-slide imaging, which allows entire slides to be imaged and permanently stored at high resolution.

In particular, whole-slide imaging serves as an enabling platform for the application of artificial intelligence (AI) in digital pathology. Until now, AI has been mostly used for image-based diagnosis in radiology and cardiology. Its application to pathology is an expanding field of active research with several research groups and dedicated companies. Images produced by whole-slide imaging are a great source of information; complexity is higher than in many other imaging modalities because of their large size (a resolution of 100k × 100k is common), presence of colour information (haematoxylin and eosin and immunohistochemistry), no apparent anatomical orientation as in radiology, availability of information at multiple scales (eg, ×4, ×20), and multiple z-stack levels (each slice contains a finite thickness and, depending on the plane of focus, will generate different images). Clearly, this kind of visual information cannot be extracted as easily by a human reader.

With integration of digital slides into the pathology workflow, advanced algorithms and computer-aided diagnostic techniques extend the frontiers of the pathologist's view beyond a microscopic slide and enable true utilisation and integration of knowledge beyond human limits and boundaries.2 AI already enables pathologists to identify unique imaging markers associated with disease processes with the goal of improving early detection, determining prognosis, and selecting treatments most likely to be effective. This allows pathologists to serve more patients while maintaining diagnostic and prognostic accuracy. This integration is especially important considering the increasing number of ageing patients, and that less than 2% of medical graduates go into pathology because of the information management, integration, and digital media accessibility aspect of the review and case sign-out process.3

Digital pathology and AI can have immense potential for oncology and precision medicine. Much like the evolution of efficiency and effectiveness in radiology, the pressure on pathologists to reduce turnaround time and develop more efficient workflows is trending towards digitalisation. This digital innovation has potential to change the way cancer diagnoses occur, with added benefits of shared images and data, increased efficiency and integrated diagnostics, modernisation of pathology workflows to improve patient care and safety, increased collaboration through multidisciplinary and disease-specific patient care conferences, improved accountability (on behalf of the physician, who makes the final clinical decision), and cost savings by optimising staff performance. By using AI algorithms many of the tasks that are manual and subjective can become more automated and standardised.

Although AI is slated to benefit many areas of clinical health sciences (eg, oncology and drug development), the focus of this Review is to highlight its use in digital pathology and whole-slide imaging, including education (eg, digital slide teaching sets), quality assurance (eg, second opinions, proficiency testing, and archiving), and clinical diagnosis (ie, telepathology). First, we explore how AI has advanced these areas of digital pathology, as well as specific use cases and applications of AI in research, image analysis, and computer-aided diagnosis; and discuss the techniques used, challenges, and barriers.1 Second, we discuss the ultimate goal of AI and whole-slide imaging—integration of pathological image information with clinical data— and its limitations. With whole-slide imaging as an enabling platform for AI, digital pathology will have meaningful and measurable effects on both clinical and research components of pathology workflow.2, 3

Section snippets

AI and education

Whole-slide imaging is already used for teaching at conferences, virtual workshops, presentations, and tumour boards.2 Equipped with whole-slide imaging, AI tools can help further training of the next generation of pathologists by providing on demand, standardised, and interactive digital slides that can be shared with multiple users anywhere, at any time.2, 3 Additionally, AI tools can provide automated annotations in the form of quizzes for trainees. With the help of these interactive tools

AI and quality assurance

The development of automated, high-speed, and high-resolution whole-slide imaging has had a substantial effect on quality assurance. Digitised slides that are readily available to pathologists in the laboratory information system or on the intranet can be used for several quality assurance tasks, including teleconsultation, gauging inter-observer and intra-observer variance, proficiency testing, and archiving of slides. For example, the College of American Pathologists optionally sends

AI for clinical diagnosis

Rendering routine pathological diagnoses using whole-slide imaging is a feasible approach. Several studies6, 7 have been published comparing diagnostic interpretation using digital slides to diagnoses rendered using glass slides and a conventional light microscope. These studies show a range of concordance from 89% to 99% when comparing diagnostic interpretation using digital slides to diagnoses rendered using glass slides and a conventional light microscope. The range is wide and encompasses

AI and image analysis

Image analysis tools can automate and quantify with greater consistency and accuracy than light microscopy. Computer-aided diagnosis is widely used for oestrogen receptor, progesterone receptor, and HER2/neu assessments in breast cancer, Ki67 assessment in carcinoid tumours, as well as multiple other clinical and research stains. The reliability of these methods requires the standardisation of the image acquisition step, which has been discussed previously. The development of whole-slide

Integration of AI with other clinical data

Histopathological image analysis is not only limited to visual analysis; several other sources of data need to be included coming from omics, clinical records, and patient demographic information.51, 52 Clinical data (eg, demographic information, medical history, and laboratory and clinical results) are mostly in unstructured free-text reports. Natural language processing technologies can be used to extract relevant information and tie those to the information in histopathological slides.53

Perception and limitations of AI

Many AI approaches, particularly systems based on deep learning, are criticised for not being able to explain how they arrive at their decisions, hence the label black boxes. Although these algorithms will still offer benefits, clinical, legal, and regulatory issues need to be sorted out going forward. At the same time, there is active research to make the algorithms easier to interpret by humans and provide insight on how they work (eg, by providing some of the features that the algorithm is

Conclusion

Pathology is rapidly transitioning to digital methods with new developments in AI. Therefore, bringing the disciplines of pathology and AI together could result in exciting changes to health care, although a large number of technical, ethical, and legal questions still need to be answered.63, 64 Combining digital pathology and AI will lead to an improved workflow and advanced diagnostics, enabling researchers and clinical teams to share and review images instantly, and use computational

Search strategy and selection criteria

We used Google Scholar and PubMed to find relevant manuscripts. We restricted our search to papers published in English between Jan 1, 2013, and Feb 25, 2019. We used the following terms in different combinations: “WSI”, “deep learning”, “AI”, “digital pathology”, “GAN”, “histopathologic image analysis”, “nuclei segmentation”, “whole slide imaging”, “artificial Intelligence and digital pathology”, “digital pathology and deep learning”, “histopathology and deep learning”, “GAN and

References (64)

  • MD Zarella et al.

    A practical guide to whole slide imaging: a white paper from the digital pathology association

    Arch Pathol Lab Med

    (2019)
  • MKK Niazi et al.

    Nuclear IHC enumeration: a digital phantom to evaluate the performance of automated algorithms in digital pathology

    PloS One

    (2018)
  • M Mirza et al.

    Conditional generative adversarial nets

  • K Tabata et al.

    Whole-slide imaging at primary pathological diagnosis: validation of whole-slide imaging-based primary pathological diagnosis at twelve Japanese academic institutes

    Pathol Int

    (2017)
  • MB Loughrey et al.

    Digital slide viewing for primary reporting in gastrointestinal pathology: a validation study

    Virchows Arch

    (2015)
  • Lloyd M, Kellough D, Shanks T, et al. How to acquire over 500 000 whole slides images a year: creating a massive novel...
  • C Senaras et al.

    DeepFocus: detection of out-of-focus regions in whole slide digital images using deep learning

    PloS One

    (2018)
  • XM Lopez et al.

    An automated blur detection method for histological whole slide imaging

    PloS One

    (2013)
  • MT Shaban et al.

    StainGAN: stain style transfer for digital histological images

  • FG Zanjani et al.

    Stain normalization of histopathology images using generative adversarial networks

  • Generative adversarial nets

  • A Bentaieb et al.

    Adversarial stain transfer for histopathology image analysis

    IEEE Trans Med Imaging

    (2018)
  • S Kothari et al.

    Removing batch effects from histopathological images for enhanced cancer diagnosis

    IEEE Trans Med Imaging

    (2014)
  • J-Y Zhu et al.

    Unpaired image-to-image translation using cycle-consistent adversarial networks

  • N Kumar et al.

    A dataset and a technique for generalized nuclear segmentation for computational pathology

    IEEE Trans Med Imaging

    (2017)
  • F Xing et al.

    Robust nucleus/cell detection and segmentation in digital pathology and microscopy images: a comprehensive review

    IEEE Rev Biomed Eng

    (2016)
  • Y Song et al.

    Accurate segmentation of cervical cytoplasm and nuclei based on multiscale convolutional network and graph partitioning

    IEEE Rev Biomed Eng

    (2015)
  • F Xing et al.

    An automatic learning-based framework for robust nucleus segmentation

    IEEE Trans Med Imaging

    (2016)
  • JN Weinstein et al.

    The cancer genome atlas pan-cancer analysis project

    Nature genetics

    (2013)
  • F Mahmood et al.

    Deep adversarial training for multi-organ nuclei segmentation in histopathology images

  • S Yousefi et al.

    Transfer learning from nucleus detection to classification in histopathology images

    BioRxiv

    (2019)
  • Cited by (644)

    View all citing articles on Scopus
    View full text